Bristol-Myers Squibb Co - BMY

New Technology Using Biometrics Detects If Security Guards Are Attacke... 1 hrs ago - PR Newswire

Astellas Pharma Inc. Is First Japanese Pharma Company to Join SAFE-Bio... 5 hrs ago - Business Wire

AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAV... 10 hrs ago - Business Wire

Research and Markets: Soft Tissue Sarcoma - Pipeline Review Market Rep... 21 hrs ago - Business Wire

One in Four Surveyed EU5 Physicians Has Been Required to Change a Pres... 18 Jun 2013 - PR Newswire

Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life ... 18 Jun 2013 - Business Wire

/C O R R E C T I O N -- Rheingold, Valet, Rheingold, McCartney & Giuff... 17 Jun 2013 - PR Newswire

Litigation Settlements, Data Compliance Reviews, and Clinical Trials P... 17 Jun 2013 - PR Newswire

Ambrx And Zhejiang Medicine Co. Ltd. Form Collaboration To Develop And... 17 Jun 2013 - PR Newswire

Ambrx and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and... 16 Jun 2013 - PR Newswire

Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Dat... 15 Jun 2013 - Business Wire

DuPont and Ogilvy Public Relations Win PRSA Best of Silver Anvil Award 14 Jun 2013 - PR Newswire

AstraZeneca and Bristol-Myers Squibb to Present New Data at American D... 14 Jun 2013 - Business Wire

Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and C... 14 Jun 2013 - Business Wire

Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and C... 14 Jun 2013 - PR Newswire

Turkey's Non-Small-Cell Lung Cancer Drug Market Projected to Grow at 7... 13 Jun 2013 - PR Newswire

Research and Markets: Cancer Diagnostics Partnering Terms and Agreemen... 13 Jun 2013 - Business Wire

Research and Markets: Infectives Partnering Terms and Agreements Repor... 12 Jun 2013 - Business Wire

Research and Markets: The Global Melanoma Therapeutics Market to Grow ... 12 Jun 2013 - Business Wire

Research and Markets: Musculoskeletal Partnering Terms and Agreements ... 12 Jun 2013 - Business Wire

AstraZeneca and Bristol-Myers Squibb Statement on Proposal by the Amer... 12 Jun 2013 - Business Wire

Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Can... 12 Jun 2013 - PR Newswire

ORENCIA® (abatacept) Shows Comparable Efficacy to Humira® (adalimumab)... 11 Jun 2013 - Business Wire

Star Life Sciences Medical Monitor Research Captures Healthcare Commun... 11 Jun 2013 - Business Wire

Research and Markets: PharmaPoint: Hepatitis C Virus - Current and Fut... 11 Jun 2013 - Business Wire

Life Science Marketing Executive Michelle Dockhorn Joins SCORR Marketi... 11 Jun 2013 - Business Wire

Sunesis Pharmaceuticals Appoints Steve Carchedi to Board of Directors 11 Jun 2013 - Globe Newswire

New AB SCIEX Mass Spectrometry Solutions Improve Identification and Qu... 10 Jun 2013 - Business Wire

Emerging Targeted Therapies Offer Efficacy Advantages Over Currently U... 10 Jun 2013 - PR Newswire

The Deal Announces Candidates For Sixth Annual Most Admired Corporate ... 10 Jun 2013 - PR Newswire

Organovo Appoints Tamar D. Howson to Board of Directors 10 Jun 2013 - PR Newswire

Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Direct... 10 Jun 2013 - Globe Newswire

RBCC Explores New Funding for Expansion 10 Jun 2013 - Business Wire

AB SCIEX Drives 6500 Series to Top of Triple Quadrupole Market 07 Jun 2013 - Business Wire

Research and Markets: Competitor Analysis: Anthrax Vaccines & Therapeu... 07 Jun 2013 - Business Wire

AMRI Announces Appointment of William Marth as Chairman of the Board o... 05 Jun 2013 - PR Newswire

Research and Markets: Hormone Refractory (Castration Resistant, Androg... 05 Jun 2013 - Business Wire

Research and Markets: Skin Cancer - Pipeline Review, H1 2013 Features ... 05 Jun 2013 - Business Wire

Bristol-Myers Squibb to Take Part in Goldman Sachs Global Healthcare C... 05 Jun 2013 - Business Wire

Research and Markets: Pancreatic Cancer - Pipeline Review, H1 2013 Giv... 05 Jun 2013 - Business Wire

LexisNexis CounselLink Seminar: Legal Departments Under Pressure 05 Jun 2013 - Business Wire

RBCC Poised To Gain Share Of $142 Billion Market 05 Jun 2013 - Business Wire

Research and Markets: Biological Product (except Diagnostic) Manufactu... 04 Jun 2013 - Business Wire

Turkey's Hepatitis C Virus Drug Market Will More Than Triple by 2017 04 Jun 2013 - PR Newswire

U.S. FDA Grants Priority Review to Bristol-Myers Squibb and AstraZenec... 04 Jun 2013 - Business Wire

Mirna Therapeutics Appoints Dr. Sinil Kim as Chief Medical Officer 04 Jun 2013 - Business Wire

MRM Leverages Vine for 2nd Annual "I am MRM" Contest 03 Jun 2013 - PR Newswire

TransCelerate BioPharma Inc. Reveals Collaborative Methodology for Ris... 03 Jun 2013 - PR Newswire

Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding 03 Jun 2013 - PR Newswire

Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combin... 02 Jun 2013 - Business Wire

Prometheus Laboratories Launches PROCLIVITY 02, a Phase IV Multi-Cente... 30 May 2013 - PR Newswire

Medivir: An all-oral combination phase II study of Simeprevir and Sama... 30 May 2013 - Business Wire

RBCC to Drive Growth Through Personalized Medicine 30 May 2013 - Business Wire

Wake Forest Innovations And New York College Of Health Professions Sig... 29 May 2013 - PR Newswire

Ligand Provides New Corporate Presentation at Investor Conference 29 May 2013 - Business Wire

European Commission Approves Stribild®, a New Single Tablet Regimen fo... 28 May 2013 - Business Wire

Model N to Present at the Raymond James Internet & Software Crossover ... 24 May 2013 - Business Wire

BioNJ Announces Keynote Speakers for BioP 4th Annual International Bio... 24 May 2013 - Business Wire

Research and Markets: Personalized Medicine Market Analysis Report: 20... 23 May 2013 - Business Wire

The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Beg... 23 May 2013 - PR Newswire

Ligand to Present at Upcoming Investor Conferences 23 May 2013 - Business Wire

Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 22 May 2013 - PR Newswire

Achieve Business Excellence While Reducing Costs with AuraPortal's Inn... 22 May 2013 - PR Newswire

Q1 Productions Hosts 2nd Annual Strengthening Patient Advocacy Relatio... 21 May 2013 - Business Wire

Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire

Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire

RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Deliv... 21 May 2013 - Business Wire

Bristol-Myers Squibb Co (BMY :)

SPECIAL OFFER